BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

To Purchase this product, please visit

https://dev.store.wiley.com/en-au/BACE%3A+Lead+Target+for+Orchestrated+Therapy+of+Alzheimer's+Disease-p-9780470293423

BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Varghese John

Available on Wiley Online Library

Description

This book covers virtually all aspects of the rapidly developing field of beta secretase (BACE), from the original isolation and cloning of BACE, to the discovery of various classes of BACE inhibitors, to challenges in clinical development. This 360 degree resource provides every member of the diverse drug-discovery team with global understanding essential for productive and successful drug discovery. It also offers researchers and clinicians an overview of the groundbreaking progress that has been made to develop inhibitors of BACE as efficacious treatments for Alzheimer's disease.

About the Author

VARGHESE JOHN is Director of Alzheimer's Drug Discovery at the Buck Institute for Age Research. He is a chemist with many years of pharmaceutical industry experience in discovery and development of drugs for CNS diseases with a primary focus on Alzheimer's disease (AD). Dr. John has many publications and patents to his credit.

To Purchase this product, please visit

https://dev.store.wiley.com/en-au/BACE%3A+Lead+Target+for+Orchestrated+Therapy+of+Alzheimer's+Disease-p-9780470293423